As of 2026-11-15, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 21.0x | 20.0x |
| Forward P/E multiples | 15.6x - 18.4x | 17.7x |
| Fair Price | (11.18) - (11.66) | (11.81) |
| Upside | -173.3% - -176.5% | -177.4% |
| Date | EV/EBITDA |